Skip to main content

CORRECTION: Gates Foundation, Synlogic Collaborate On Technology Application

GenomeWeb Daily News was provided incorrect information that the $5 million was in addition to the $29.4 million that Synlogic raised in July. The summer financing included the $5 million.

NEW YORK (GenomeWeb) – Synthetic biology firm Synlogic today announced it and the Bill & Melinda Gates Foundation will collaborate as part of a $5 million investment from the foundation into Synlogic's Series A financing round in July that raised $29.4 million.

Synlogic previously announced that Atlas Venture and New Enterprise Associates invested in the Series A round. The Cambridge, Mass.-based firm today said that along with developing its technology platform and therapeutic applications, it will collaborate with the Gates Foundation on applications for its technology that are relevant to the developing world.

Synlogic's technology is based on bacteria that sense physiologic changes, perform a therapeutic action, and then deactivate themselves. In a statement, Trevor Mundel, president of global health for the Gates Foundation, said that the firm's technology could result in new therapies for the most severe diarrheal diseases, the second-leading cause of death for children in developing nations.

Synlogic also announced Paul Miller has joined the company as CSO and Alison Silva has joined it as Chief Operating Officer.

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.